Filing Flows

Filing Flows › 13F managers › T. Rowe Price Investment Management, Inc.

T. Rowe Price Investment Management, Inc.: 13F portfolio Q2 2026 and what copying it returned

T. Rowe Price Investment Management, Inc.'s 13F for the quarter ended 2026-06-30 (filed Aug 14, 2026): 400 common-share positions, $152.6B reported. Copying each 13F the day after it was filed returned +15.5% from May 16, 2025 to Nov 6, 2026, against +24.5% for SPY.

Reported 13F assets$152.6B
Positions (common)400
Quarter2026-06-30
Clone return+15.5%
SPY, same days+24.5%
Clone max drawdown-10.5%

Copying the 13F

2025-052025-082025-112026-022026-052026-082026-11cloneSPY

Each 13F bought at the close of the first trading day after it was filed and held, drifting, until the next one; value-weighted over the common-share positions with a price (93.0% of the portfolio on average); 6 filings since May 14, 2025. Price returns for the clone and SPY alike (no dividends, no costs). A 13F lists only US long positions at quarter end, reported up to 45 days later.

Largest holdings (2026-06-30)

T. Rowe Price Investment Management, Inc.: largest 13F holdings, 2026-06-30T. Rowe Price Investment Management, Inc.: largest 13F holdings, 2026-06-30AMZN · Amazon.com$4.0BMSFT · Microsoft$3.9BNVDA · NVIDIA$3.4BGOOGL · Alphabet$3.0BAVGO · Broadcom$3.0BCNP · CenterPoint Energy$2.9BMETA · Meta Platforms$2.6BAMD · Advanced Micro Devices$2.2BAAPL · Apple$2.2BCOR · Cencora$2.1BAUR · Aurora Innovation$2.0BRVTY · Revvity$2.0BMA · Mastercard$1.8BGOOG · Alphabet$1.7BALNY · Alnylam Pharmaceuticals$1.7B
TickerCompanyWeightValueChange in the quarter
AMZNAmazon.com2.6%$4.0B-33.5%
MSFTMicrosoft2.6%$3.9B-17.1%
NVDANVIDIA2.2%$3.4B-13.2%
GOOGLAlphabet2.0%$3.0B-5.0%
AVGOBroadcom1.9%$3.0B+23.0%
CNPCenterPoint Energy1.9%$2.9B+12.0%
METAMeta Platforms1.7%$2.6B-31.8%
AMDAdvanced Micro Devices1.5%$2.2B-48.8%
AAPLApple1.4%$2.2B-52.1%
CORCencora1.4%$2.1B+17.7%
AURAurora Innovation1.3%$2.0B+2.6%
RVTYRevvity1.3%$2.0B-17.7%
MAMastercard1.2%$1.8B+64.9%
GOOGAlphabet1.1%$1.7B+21393.0%
ALNYAlnylam Pharmaceuticals1.1%$1.7B+8.6%
YUMYum Brands1.1%$1.6B+4.0%
CYTKCytokinetics1.1%$1.6B+6.8%
PTCPTC1.0%$1.5B-31.7%
WATWaters0.9%$1.4B-18.1%
NINiSource0.9%$1.4B-40.1%
AEEAmeren0.9%$1.4B+61.0%
IRIngersoll Rand0.9%$1.3B-9.7%
DHRDanaher0.9%$1.3B+82.8%
MUMicron Technology0.8%$1.3B+76.3%

Biggest adds

Biggest cuts

Track record

Of 530 position changes scored in 530 separate decisions, 52.1% were on the right side of SPY over the next three months (Disclosures → Smart money).

Open in Disclosures → every quarter, the clone month by month, the smart-money record

Source: SEC Form 13F-HR, filer CIK 1897612. Not investment advice.